Subscribe to Newsletter

Content by Maryam Mahdi:

 Business & Regulation Business Practice

Creating Value at All Levels

| Maryam Mahdi

Sitting Down With... JoyL Silva, General Manager at PfizerCentre.
Discovery & Development Drug Discovery

The Good, The Bad and The Side Effects

| Maryam Mahdi

How can drugs be modified to lessen their adverse effects?
Business & Regulation Business Practice

If You Build It, They Will Come

| Maryam Mahdi

Sitting Down With... Kelly Chibale, Director, H3D, University of Cape Town, South Africa.
Manufacture Supply Chain

The Supported Supply Chain

| Maryam Mahdi

What role can CMOs play in the fight against fakes?
Business & Regulation Vaccines

For a Better Future

| Maryam Mahdi

The Global Vaccine Summit raised funds to improve international immunization programs.
Manufacture COVID-19

The Rise of the COVID-19 Scammer

| Maryam Mahdi

How are counterfeiters taking advantage of the COVID-19 pandemic?
Discovery & Development Clinical Trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.
Discovery & Development Drug Discovery

COVID-19: Llamas to the Rescue

| Maryam Mahdi

Llama antibodies may be crucial in the fight against COVID-19.
Business & Regulation Business Practice

The Great Rebrander

| Maryam Mahdi

What makes pharma so good at rebranding?
Discovery & Development Drug Discovery

Intelligent Repurposing

| Maryam Mahdi

An AI platform seeks out drugs that can be repurposed to treat COVID-19.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker